Henri Steenkamp
Analyst · Ladenburg. Your line is now open
Thank you, Chris. Slide 4 highlights our key performance metrics for the quarter ended November 30, 2018. Across all these metrics, you can see the positive impact of increased assets while maintaining strong credit quality. When adjusting for the incentive fee accrual related to net unrealized capital gains in the second incentive fee calculation, adjusted NII of $4.85 million was up 1.9% from $4.76 million last quarter and up 49% from $3.3 million as compared to last year’s Q3. Adjusted NII per share was $0.65, up $0.11 from $0.54 per share last year and down $0.04 from $0.69 per share last quarter. The increase from last year primarily reflects our higher level of investments and resultant higher interest income with AUM up 31% from last year. The sequential quarterly decrease was primarily due to last quarter’s deferred tax benefit not repeating, as well as the full impact of Q2’s equity raise and increased outstanding shares. Adjusted NII yield was 11.2%. This yield is up 160 basis points from 9.6% last year but down 70 basis points from 11.9% last quarter. For this third quarter, we experienced a net loss on investments of $1.5 million or $0.20 per weighted average share, resulting in a total increase in net assets resulting from operations of $3.7 million or $0.49 per share. The $1.5 million net loss on investments was comprised of $1.0 million in net unrealized depreciation and $0.4 million of net deferred tax expense on unrealized gains in Saratoga Investment’s block of subsidiaries. The $1.0 million unrealized depreciation includes two discrete unrealized depreciation items: first, a $1.6 million unrealized depreciation on the Saratoga CLO, mostly reflecting the transaction fees of the refinancing and upsizing that closed post-quarter end; and second, a $0.7 million unrealized depreciation on the company’s Health Media Network investment, reflecting a partial reduction of previously recognized unrealized gains. This adjustment was necessary to reflect the value that has actually been realized subsequent to quarter end with our full debt, equity and warrant positions being redeemed in early December for a total realized gain of $4.7 million on our overall HMN investment. Excluding these two investments, the remaining fair value changes across the total portfolio for Q3 is unrealized appreciation of $1.2 million. We continue to focus on return on equity as an important performance indicator for us, which also includes both the realized and unrealized gains. Our return on equity was 10.1% for the last 12 months, similar to last year’s 10.2% but well above the BDC industry average of 9.6%. Quickly touching on expenses, total expenses excluding interest and debt financing expenses, base management fees and incentive management fees, increased to $1.3 million this quarter from $1.2 million in the same period last year, reflecting primarily the increase in the administrator expenses cap earlier in the year. Expenses as a percentage of average total assets decreased from 1.4% to 1.2%. We have also again added the KPI slide starting from Slide 27 in the appendix at the end of the presentation, that shows our income statement and balance sheet metrics for the past nine quarters and the upward trends we have maintained. Of particular note is Slide 30, highlighting how our net interest margin run rate has more than tripled since Saratoga took over management of the BDC. Moving on to Slide 5, NAV this quarter was $173.3 million at quarter end, a $29.6 million increase from NAV of $143.7 million at year-end and a $34.5 million increase from NAV of $138.8 million as of 12 months ago. NAV per share was $23.13 as of quarter end, up from $22.96 as of year-end and $22.58 as of the same period last year. For the nine months ended November 30, 2018, $14.2 million of NII and $0.1 million of net realized gains were earned, offset by $1.2 million of deferred tax expense on net unrealized gains in our block of subsidiaries, $2.5 million net unrealized depreciation on investments, and $10.2 million of dividends declared. In addition, $1.5 million of stock dividend distributions were made through the company’s DRIP plan. 10,373 shares were also sold through the company’s ATM equity offering during the year. Our net asset value per share has also steadily increased over the past couple of years, as seen on Slide 27, and we continue to benefit from our history of consistent realized gains. On Slide 6, you will see a simply reconciliation of the major changes in NII and NAV per share on a sequential quarterly basis. Starting at the top, NII per share decreased from $0.69 per share last quarter to $0.65 this quarter. The significant changes were a $0.07 increase in net interest margin, excluding the CLO, reflecting the increase in our asset base offset by a $0.03 decrease in Q2’s deferred tax benefit and a $0.05 dilution from increased shares due to the equity offering and DRIP issuance. All changes are shown net of incentive fees. Moving on to the lower half of the slide, this reconciles the $0.03 NAV per share decrease for the quarter. The $0.69 generated by our NII in Q3 is offset by the $0.52 dividend declared for Q2 with a Q3 record date, and a $0.20 net realized and unrealized loss on investments. Slide 7 outlines the dry powder available to us as of quarter end, which totaled $37.4 million. This is spread between our available cash and undrawn Madison facility. This quarter, we invested substantially all of the capital raised during Q2’s equity raise and new baby bond issuance. We remain pleased with our liquidity position, especially taking into account the overall conservative nature of our balance sheet and the fact that all our debt is long term in nature, actually all five years-plus. For the most part, we have also primarily fixed our interest cost in this rising rate environment with all our borrowings, except our Madison facility, being fixed rate--apologies, floating rate. Moving across to the asset side of our balance sheet on Slide 8, 83% of our investments have floating rates, and although they have LIBOR floors, we are through all of them which means we remain a big beneficiary of the rising short-term rates. Assuming that our investments as of quarter end were to remain constant for a full fiscal quarter and no actions were taken to alter the existing rate terms, a hypothetical increase of 100 basis points in interest rates would increase our interest income by approximately $0.8 million per quarter or 7% as compared to our current interest income. This is all incremental to our existing earnings without any other changes. Now I would like to move on to Slides 9 through 11 and review the composition and yield of our investment portfolio. Slide 9 shows that our composition and weighted average current yield remained relatively consistent with the past, with $443.8 million invested in 36 portfolio companies and one CLO fund, and 53.6% of our investments in first lien. On Slide 10, you can see how the yield on our core BDC assets, excluding our CLO and syndicated loans, as well as our total assets yield has remained relatively consistent in the 11% or just above range for the past several years, despite high levels of repayments and the continued replacement of these assets. This quarter, our overall yield as compared to Q2 remained unchanged at 10.8%. Core BDC asset yields increased slightly to 11.3%. That increase is primarily due to the increase in LIBOR rates this quarter. The weighted average yield of our CLO decreased to 13.3% as we factored in the impact of the refinancing that closed in December. Turning to Slide 11, during the third fiscal quarter we made investments of $73.7 million in one new portfolio company and nine follow-ons, and had $23.4 million in amortizations and one repayment resulting in a net increase in investments of $50.3 million. Our investments still remain highly diversified by type as well as in terms of geography and industry, spread over 10 distinct industries with a large focus on business, healthcare, and education services, and business services is also spread amongst numerous end markets. We continue to have no direct exposure to the oil and gas industry. Of our total investment portfolio, consistent with Q2 and following the large originations this quarter, 9.1% consists of equity interests, which remain an important part of our overall investment strategy. For the past six fiscal years including Q3, we had a combined $12.0 million of net realized gains from the sale of equity interests or sale or early redemption of other investments. When factoring in our available NOLs, these are similar to equity raises for us. This consistent performance continues to be a good indicator of our portfolio credit quality, has helped grow our NAV, and is reflected in our healthy long-term ROE. That concludes my financial and portfolio review. I will now turn the call over to Michael Grisius, our President and Chief Investment Officer, for an overview of the investment market.